In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus
Identifieur interne : 001C73 ( PascalFrancis/Curation ); précédent : 001C72; suivant : 001C74In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus
Auteurs : L. Cegolon [Italie, Royaume-Uni] ; C. Salata [Italie] ; E. Piccoli [Italie] ; V. Juarez [France] ; G. Palu' [Italie] ; G. Mastrangelo [Italie] ; A. Calistri [Italie]Source :
- International journal of hygiene and environmental health [ 1438-4639 ] ; 2014.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Santé publique.
English descriptors
- KwdEn :
Abstract
Influenza virus spreads via small particle aerosols, droplets and fomites, and since it can survive for a short time on surfaces, can be introduced into the nasal mucosa before it loses infectivity. The hypothiocyanite ion (OSCN-), product of the lactoperoxidase/H2O2/SCN- system of central airways, is emerging as an important molecule for innate defense mechanism against bacteria, fungi and viruses. Here we demonstrated that OSCN- displays virucidal activity in vitro against the A/H1N1 2009 pandemic influenza virus. The concentration required to inhibit viral replication by 50% was 2 μM when virus were challenged directly with OSCN- before cell inoculation. These values were even lower when inoculated cells were maintained in contact with enzyme free-OSCN- in the culture medium. The last experimental conditions better reflect those of tracheobronchial mucosa, where HOSCN/OSCN- is retained in the air-liquid interface and inactivates both the viruses approaching the epithelium from outside and those released from the inoculated cells after the replication cycle. Importantly no OSCN- cytotoxicity was observed in the cellular system employed. The lack of toxicity in humans and the absence of damage on surfaces of fomites suggest a potential use of OSCN- to avoid mucosal and environmental transmission of influenza virus. Since hypothiocyanite is normally present in human airways a low risk of viral resistance is envisaged. In vivo confirmatory studies are needed to evaluate the appropriate dose, regimen and formulation.
pA |
|
---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000145
Links to Exploration step
Pascal:14-0075821Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus</title>
<author><name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Imperial College London, School of Public Health, St. Mary's Campus</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Alaxia SAS</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0075821</idno>
<date when="2014">2014</date>
<idno type="stanalyst">PASCAL 14-0075821 INIST</idno>
<idno type="RBID">Pascal:14-0075821</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000145</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001C73</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus</title>
<author><name sortKey="Cegolon, L" sort="Cegolon, L" uniqKey="Cegolon L" first="L." last="Cegolon">L. Cegolon</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Imperial College London, School of Public Health, St. Mary's Campus</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Salata, C" sort="Salata, C" uniqKey="Salata C" first="C." last="Salata">C. Salata</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Piccoli, E" sort="Piccoli, E" uniqKey="Piccoli E" first="E." last="Piccoli">E. Piccoli</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Juarez, V" sort="Juarez, V" uniqKey="Juarez V" first="V." last="Juarez">V. Juarez</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Alaxia SAS</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Palu, G" sort="Palu, G" uniqKey="Palu G" first="G." last="Palu'">G. Palu'</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Mastrangelo, G" sort="Mastrangelo, G" uniqKey="Mastrangelo G" first="G." last="Mastrangelo">G. Mastrangelo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Calistri, A" sort="Calistri, A" uniqKey="Calistri A" first="A." last="Calistri">A. Calistri</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">International journal of hygiene and environmental health</title>
<title level="j" type="abbreviated">Int. j. hyg. environ. health : (print)</title>
<idno type="ISSN">1438-4639</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">International journal of hygiene and environmental health</title>
<title level="j" type="abbreviated">Int. j. hyg. environ. health : (print)</title>
<idno type="ISSN">1438-4639</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>2009</term>
<term>Antiviral</term>
<term>Biological activity</term>
<term>Check</term>
<term>Disinfection</term>
<term>Environmental medicine</term>
<term>H1N1 influenza</term>
<term>Health and environment</term>
<term>In vitro</term>
<term>Infection</term>
<term>Influenzavirus</term>
<term>Prevention</term>
<term>Public health</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Infection</term>
<term>Activité biologique</term>
<term>In vitro</term>
<term>Antiviral</term>
<term>2009</term>
<term>Santé publique</term>
<term>Influenzavirus</term>
<term>Prévention</term>
<term>Traitement</term>
<term>Contrôle</term>
<term>Désinfection</term>
<term>Santé et environnement</term>
<term>Médecine environnementale</term>
<term>Pandémie</term>
<term>Grippe H1N1</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Santé publique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Influenza virus spreads via small particle aerosols, droplets and fomites, and since it can survive for a short time on surfaces, can be introduced into the nasal mucosa before it loses infectivity. The hypothiocyanite ion (OSCN<sup>-</sup>
), product of the lactoperoxidase/H<sub>2</sub>
O<sub>2/</sub>
SCN<sup>-</sup>
system of central airways, is emerging as an important molecule for innate defense mechanism against bacteria, fungi and viruses. Here we demonstrated that OSCN<sup>-</sup>
displays virucidal activity in vitro against the A/H1N1 2009 pandemic influenza virus. The concentration required to inhibit viral replication by 50% was 2 μM when virus were challenged directly with OSCN<sup>-</sup>
before cell inoculation. These values were even lower when inoculated cells were maintained in contact with enzyme free-OSCN<sup>-</sup>
in the culture medium. The last experimental conditions better reflect those of tracheobronchial mucosa, where HOSCN/OSCN<sup>-</sup>
is retained in the air-liquid interface and inactivates both the viruses approaching the epithelium from outside and those released from the inoculated cells after the replication cycle. Importantly no OSCN<sup>-</sup>
cytotoxicity was observed in the cellular system employed. The lack of toxicity in humans and the absence of damage on surfaces of fomites suggest a potential use of OSCN<sup>-</sup>
to avoid mucosal and environmental transmission of influenza virus. Since hypothiocyanite is normally present in human airways a low risk of viral resistance is envisaged. In vivo confirmatory studies are needed to evaluate the appropriate dose, regimen and formulation.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>1438-4639</s0>
</fA01>
<fA03 i2="1"><s0>Int. j. hyg. environ. health : (print)</s0>
</fA03>
<fA05><s2>217</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>CEGOLON (L.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SALATA (C.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>PICCOLI (E.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>JUAREZ (V.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>PALU' (G.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>MASTRANGELO (G.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>CALISTRI (A.)</s1>
</fA11>
<fA14 i1="01"><s1>Padua University, Department of Molecular Medicine</s1>
<s2>Padua</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Imperial College London, School of Public Health, St. Mary's Campus</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Alaxia SAS</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>17-22</s1>
</fA20>
<fA21><s1>2014</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>7500</s2>
<s5>354000505792760030</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>3/4 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0075821</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>International journal of hygiene and environmental health</s0>
</fA64>
<fA66 i1="01"><s0>DEU</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Influenza virus spreads via small particle aerosols, droplets and fomites, and since it can survive for a short time on surfaces, can be introduced into the nasal mucosa before it loses infectivity. The hypothiocyanite ion (OSCN<sup>-</sup>
), product of the lactoperoxidase/H<sub>2</sub>
O<sub>2/</sub>
SCN<sup>-</sup>
system of central airways, is emerging as an important molecule for innate defense mechanism against bacteria, fungi and viruses. Here we demonstrated that OSCN<sup>-</sup>
displays virucidal activity in vitro against the A/H1N1 2009 pandemic influenza virus. The concentration required to inhibit viral replication by 50% was 2 μM when virus were challenged directly with OSCN<sup>-</sup>
before cell inoculation. These values were even lower when inoculated cells were maintained in contact with enzyme free-OSCN<sup>-</sup>
in the culture medium. The last experimental conditions better reflect those of tracheobronchial mucosa, where HOSCN/OSCN<sup>-</sup>
is retained in the air-liquid interface and inactivates both the viruses approaching the epithelium from outside and those released from the inoculated cells after the replication cycle. Importantly no OSCN<sup>-</sup>
cytotoxicity was observed in the cellular system employed. The lack of toxicity in humans and the absence of damage on surfaces of fomites suggest a potential use of OSCN<sup>-</sup>
to avoid mucosal and environmental transmission of influenza virus. Since hypothiocyanite is normally present in human airways a low risk of viral resistance is envisaged. In vivo confirmatory studies are needed to evaluate the appropriate dose, regimen and formulation.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B03</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B30A02A</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B02S05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Infection</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Infection</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Infección</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Activité biologique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Biological activity</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Actividad biológica</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>In vitro</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>In vitro</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>In vitro</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Antiviral</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>2009</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>2009</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>2009</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Public health</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Influenzavirus</s0>
<s2>NW</s2>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Prévention</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Prevention</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Prevención</s0>
<s5>11</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Traitement</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Treatment</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>12</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Contrôle</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Check</s0>
<s5>17</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Control</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Désinfection</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Disinfection</s0>
<s5>18</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Desinfección</s0>
<s5>18</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Santé et environnement</s0>
<s5>25</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Health and environment</s0>
<s5>25</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Salud y medio ambiente</s0>
<s5>25</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Médecine environnementale</s0>
<s5>26</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Environmental medicine</s0>
<s5>26</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Medicina ambiental</s0>
<s5>26</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Pandémie</s0>
<s4>INC</s4>
<s5>86</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE"><s0>Grippe H1N1</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG"><s0>H1N1 influenza</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA"><s0>Gripe H1N1</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Orthomyxoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Virose</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Viral disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Virosis</s0>
<s5>38</s5>
</fC07>
<fN21><s1>104</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C73 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001C73 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= PascalFrancis |étape= Curation |type= RBID |clé= Pascal:14-0075821 |texte= In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus }}
This area was generated with Dilib version V0.6.34. |